title: Upper and middle lobe bronchoalveolar lavage to diagnose Pneumocystis carinii pneumonia.
abstract: Pneumocystis carinii pneumonia (PCP) remains the most common lethal opportunistic pulmonary infection in patients infected with the human immunodeficiency virus (HIV). Although the use of prophylactic inhaled pentamidine has effectively reduced the frequency of primary and recurrent episodes of PCP, the aerosolization of pentamidine may have altered the localization of active PCP, resulting in more upper lobe disease. The distribution of disease may have also affected the diagnostic accuracy of standard bronchoalveolar lavage of the middle lobe, with a reduction in sensitivity from about 90 to 65%. In retrospective surveys of patients from our institution, Steiger and Fahy found that pooled multiple-lobe radiographic site-directed bronchoalveolar lavage resulted in diagnostic sensitivities of 91 and 100%, respectively. We performed a follow-up prospective study of 38 consecutive patients on aerosolized pentamidine in whom we lavaged both the middle lobe and an upper lobe. We found that bilobar lavage including routine lavage of an upper lobe increases the diagnostic sensitivity of bronchoalveolar lavage alone to 95% compared with 65% if lavage is performed only in the middle lobe (p < 0.05). Radiographic studies demonstrate a concordant increase in exclusive or predominant upper lobe disease in patients on aerosolized pentamidine, but our results indicate that PCP is recovered more frequently from the upper lobe regardless of the radiographic appearance. We conclude that all patients on prophylactic inhaled pentamidine should undergo bilobar lavage with the inclusion of an upper lobe in the initial evaluation of possible PCP. The diagnostic sensitivity of 95% makes bilobar bronchoalveolar lavage an acceptable sole initial diagnostic modality without the need for initial transbronchial lung biopsy.
authors.affiliation: Department of Medicine, University of California at San Francisco 94143-0854.
authors.forename: R C
authors.initials: RC
authors.lastname: Yung
authors.forename: A B
authors.initials: AB
authors.lastname: Weinacker
authors.forename: D J
authors.initials: DJ
authors.lastname: Steiger
authors.forename: T R
authors.initials: TR
authors.lastname: Miller
authors.forename: E J
authors.initials: EJ
authors.lastname: Stern
authors.forename: C J
authors.initials: CJ
authors.lastname: Salmon
authors.forename: D N
authors.initials: DN
authors.lastname: Chernoff
authors.forename: M G
authors.initials: MG
authors.lastname: Luistro
authors.forename: S
authors.initials: S
authors.lastname: Kuntz
authors.forename: J A
authors.initials: JA
authors.lastname: Golden
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000175:diagnosis* / Q000000981:diagnostic imaging; D001992:Bronchoalveolar Lavage Fluid; D006801:Humans; D008168:Lung / Q000000981:diagnostic imaging; D011020:Pneumonia, Pneumocystis / Q000175:diagnosis* / Q000000981:diagnostic imaging; D011446:Prospective Studies; D011859:Radiography; D012680:Sensitivity and Specificity